Andrographis is becoming an immune-resilience shelf staple

Andrographis sits in a category consumers already understand: immune support. The reason it belongs in Foresight is that immune products are becoming more segmented. People no longer want only vitamin C, zinc, and elderberry. They want respiratory-season readiness, travel support, workplace exposure support, and products that feel stronger without becoming drug claims.

The first winning formats are likely capsules, liquid shots, immune-season bundles, and travel packs. Andrographis can also pair with probiotics, vitamin D, zinc, mushrooms, or polyphenols, but the core appeal is a bitter, serious botanical with a long traditional-use story and a more modern extract pathway.

Southeast Asia and India are central to the supply and traditional-use story, while Australia and Europe already have consumers comfortable with herbal immune products. In the U.S., the category would likely enter through premium immune brands, pharmacy-adjacent supplements, and direct-selling networks that can explain the ingredient carefully.

The companies to watch are standardized extract suppliers, pharmacy private labels, travel-health brands, and wellness companies that already own immune-season customers. The signal gets stronger when andrographis products show clean safety labeling, repeat purchase, and retailer trust.